These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

676 related articles for article (PubMed ID: 10630643)

  • 41. Cyclooxygenase-2 inhibitors in lung cancer.
    Ramalingam S; Belani CP
    Clin Lung Cancer; 2004 Jan; 5(4):245-53. PubMed ID: 14967078
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The role of COX-2 in intestinal cancer.
    Williams C; Shattuck-Brandt RL; DuBois RN
    Ann N Y Acad Sci; 1999; 889():72-83. PubMed ID: 10668484
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Renal abnormalities and an altered inflammatory response in mice lacking cyclooxygenase II.
    Dinchuk JE; Car BD; Focht RJ; Johnston JJ; Jaffee BD; Covington MB; Contel NR; Eng VM; Collins RJ; Czerniak PM
    Nature; 1995 Nov; 378(6555):406-9. PubMed ID: 7477380
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cyclooxygenases and colon cancer.
    Kawai N; Tsujii M; Tsuji S
    Prostaglandins Other Lipid Mediat; 2002 Aug; 68-69():187-96. PubMed ID: 12432918
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cyclooxygenases 1 and 2.
    Vane JR; Bakhle YS; Botting RM
    Annu Rev Pharmacol Toxicol; 1998; 38():97-120. PubMed ID: 9597150
    [TBL] [Abstract][Full Text] [Related]  

  • 46. COX-2 and colon cancer.
    Taketo MM
    Inflamm Res; 1998 Oct; 47 Suppl 2():S112-6. PubMed ID: 9831333
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cyclooxygenase-2 expression in right- and left-sided colon cancer: a rationale for optimization of cyclooxygenase-2 inhibitor therapy.
    Nasir A; Kaiser HE; Boulware D; Hakam A; Zhao H; Yeatman T; Barthel J; Coppola D
    Clin Colorectal Cancer; 2004 Feb; 3(4):243-7. PubMed ID: 15025797
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Nociception in cyclooxygenase isozyme-deficient mice.
    Ballou LR; Botting RM; Goorha S; Zhang J; Vane JR
    Proc Natl Acad Sci U S A; 2000 Aug; 97(18):10272-6. PubMed ID: 10954756
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cyclooxygenase knockout mice: models for elucidating isoform-specific functions.
    Langenbach R; Loftin C; Lee C; Tiano H
    Biochem Pharmacol; 1999 Oct; 58(8):1237-46. PubMed ID: 10487525
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Suppression of intestinal polyp development by nimesulide, a selective cyclooxygenase-2 inhibitor, in Min mice.
    Nakatsugi S; Fukutake M; Takahashi M; Fukuda K; Isoi T; Taniguchi Y; Sugimura T; Wakabayashi K
    Jpn J Cancer Res; 1997 Dec; 88(12):1117-20. PubMed ID: 9473726
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Chemopreventive effects of NSAIDs against colorectal cancer: regulation of apoptosis and mitosis by COX-1 and COX-2.
    Watson AJ
    Histol Histopathol; 1998 Apr; 13(2):591-7. PubMed ID: 9589912
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cyclooxygenase-2: a potential target in breast cancer.
    Wang D; Dubois RN
    Semin Oncol; 2004 Feb; 31(1 Suppl 3):64-73. PubMed ID: 15052544
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Suppression of intestinal polyposis in Apc delta716 knockout mice by inhibition of cyclooxygenase 2 (COX-2).
    Oshima M; Dinchuk JE; Kargman SL; Oshima H; Hancock B; Kwong E; Trzaskos JM; Evans JF; Taketo MM
    Cell; 1996 Nov; 87(5):803-9. PubMed ID: 8945508
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cyclooxygenase inhibition in cancer prevention and treatment.
    Anderson WF; Umar A; Hawk ET
    Expert Opin Pharmacother; 2003 Dec; 4(12):2193-204. PubMed ID: 14640918
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Direct evidence of the cyclooxygenase pathway of prostaglandin synthesis in arthropods: genetic and biochemical characterization of two crustacean cyclooxygenases.
    Varvas K; Kurg R; Hansen K; Järving R; Järving I; Valmsen K; Lõhelaid H; Samel N
    Insect Biochem Mol Biol; 2009 Dec; 39(12):851-60. PubMed ID: 19854273
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Review article: cyclooxygenase--a target for colon cancer prevention.
    Dubois RN
    Aliment Pharmacol Ther; 2000 Apr; 14 Suppl 1():64-7. PubMed ID: 10807405
    [TBL] [Abstract][Full Text] [Related]  

  • 57. COX-2 inhibitors and breast cancer.
    Singh Ranger G; Mokbel K
    ANZ J Surg; 2003 Aug; 73(8):565-6. PubMed ID: 12887516
    [No Abstract]   [Full Text] [Related]  

  • 58. Prognostic impact of cyclooxygenase-2 in breast cancer.
    Denkert C; Winzer KJ; Hauptmann S
    Clin Breast Cancer; 2004 Feb; 4(6):428-33. PubMed ID: 15023244
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Disruption of the mouse cyclooxygenase 1 gene. Characteristics of the mutant and areas of future study.
    Langenbach R; Morham SG; Tiano HF; Loftin CD; Ghanayem BI; Chulada PC; Mahler JF; Davis BJ; Lee CA
    Adv Exp Med Biol; 1997; 407():87-92. PubMed ID: 9321936
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Emerging role of cyclooxygenase isoforms in the control of gastrointestinal neuromuscular functions.
    Fornai M; Antonioli L; Colucci R; Bernardini N; Ghisu N; Tuccori M; De Giorgio R; Del Tacca M; Blandizzi C
    Pharmacol Ther; 2010 Jan; 125(1):62-78. PubMed ID: 19808045
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 34.